VC-backed African companies have just completed their first life cycle. The prospect of Africa generating unicorns is optimistic but achievable: it offers giant underserved markets, its companies and entrepreneurs Continue Reading
With a high population growth rate and a significantly rising GDP between 2007 and 2016, Africa undoubtedly represents a strong potential for investors. And despite some gaps, the venture capital market has a bright Continue Reading
Demand for credit in Africa exceeds supply, despite the rise in mobile money. Yet start-ups, growing daily in number, are at risk of accelerating over-indebtedness, by supplying credit to clients without conducting Continue Reading
Johann Choux, Head of Proparco’s Investments, Financial Institutions and Innovation Division, sets out the major issues tackled in this edition of the magazine.Continue Reading
Along with Asia and Latin America, Africa is currently one of the regions most affected by the trade in counterfeit drugs which account for almost one-third of pharmaceutical products on sale in these regions. The Continue Reading
Pharmivoire Nouvelle is a pioneering manufacturer of medical intravenous solutions in Côte d’Ivoire. Its 25 years’ experience are proof that locally-based production of pharma products is a realistic, sustainable Continue Reading
Pharmaceutical production grew globally over the last decades: active ingredients and finished products are manufactured across different regions, and circulate through multiple distribution channels. Sadly, Continue Reading
“Public health” oriented licenses and patent pooling in Africa promotes research and production of affordable, high quality generic treatments for AIDS, hepatitis C and tuberculosis. The United Nations Continue Reading
